硼替佐米治疗自体及非清髓性异基因移植后骨髓瘤髓外复发的疗效
Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation.
作者信息
Patriarca Francesca, Prosdocimo Simonetta, Tomadini Valentina, Vasciaveo Annarosa, Bruno Benedetto, Fanin Renato
出版信息
Haematologica. 2005 Feb;90(2):278-9.
PMID:15710593
Abstract
We report the successful use of bortezomib to treat a patient with multiple myeloma (MM) who had extramedullary relapse (paraspinal and thoracic masses and multiple cranial nerve palsy) after autologous and non-myeloablative allogeneic hematopoietic stem cell transplantation (HSCT).
摘要
我们报告了硼替佐米成功用于治疗一名多发性骨髓瘤（MM）患者的案例，该患者在自体及非清髓性异基因造血干细胞移植（HSCT）后出现髓外复发（椎旁和胸部肿块以及多条颅神经麻痹）。
Zotero 插件